News

Tiny llama antibodies, called nanobodies, have been shown to effectively neutralize human noroviruses in the lab, revealing that they could be developed into a therapeutic agent.

The liver can produce an undesired immune response, triggered by gene therapy, the discovery of which may pave the way for a change in immunomodulation strategies for long-lasting gene therapies.

An under-the-skin implant that secretes insulin could provide an easier, long-term and less invasive way to treat type 1 diabetes.

Chimeric Antigen Receptors (CARs) have opened up an exciting new field of therapeutic advancements for rare and difficult-to-treat cancers, as they have the ability to deliver targeted therapies that can kill tumor cells.

According to research, inhibiting the galectin 1 protein, which is often over-expressed in hepatocellular carcinoma (HCC) using gene therapy can shrink HCC and increase the number of killer T cells inside tumors in mice.

Made from human cells, researchers have created tiny biological robots – called Anthrobots – that can move across surfaces and even encourage regrowth in damaged regions in dishes of lab-grown neurons.

A "super power" used by plants to deter predators has inspired a new tool that may help researchers develop new pharmaceuticals in a cleaner, greener, less expensive way.

A new study has shed light on why having two copies of each chromosome is crucial, identifying a mechanism that maintains biallelic gene dosage.

An innovative stem cell-based treatment for Type 1 diabetes can meaningfully regulate blood glucose levels and reduce dependence on daily insulin injections, according to new clinical trial results.

There are plant proteins that are very similar to the human MIF protein in the sequence of their individual building blocks (amino acids) and these are referred to as MDL proteins.